In CHD, to reduce risk of death, coronary death & non-fatal MI, reduce risk for undergoing myocardial revascularisation procedures & slow progression of coronary atherosclerosis, reduce development of new lesions & new total occlusions. Adjunct to diet in patients w/ primary hypercholesterolaemia, heterozygous familial hypercholesterolaemia or mixed hyperlipidaemia when response to diet & other non-pharmacological measures is inadequate.
Dosage/Direction for Use
CHD 20 mg nightly. Max: 80 mg daily given as single evening dose. Hyperlipidaemia 20 mg nightly.